News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Conference News AHA 2017 DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy Yael L. Maxwell November 12, 2017
News Conference News AHA 2017 TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery Shelley Wood November 12, 2017
News Conference News AHA 2016 No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION Shelley Wood November 13, 2016
News Conference News AHA 2016 Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients Yael L. Maxwell November 13, 2016
News Conference News AHA 2015 AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More Shelley Wood November 05, 2015
News Conference News AHA 2014 Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts November 18, 2014
News Conference News AHA 2014 DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation Yael L. Maxwell November 16, 2014
News Conference News AHA 2013 French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients Yael L. Maxwell November 20, 2013
News Conference News PRISM Individualized Informed Consent Improves PCI Choice, Experience November 14, 2011